Written and maintained by CASRAI Editorial Board
Last updated
General product and regulatory information only. This page is not medical advice; decisions about any garment after surgery belong to the operating surgeon and care team.
Short answer
A post-surgical compression garment is an elastic garment worn over an operated area to support and compress it. In the United States, FDA regulates this kind of elastic compression product with the elastic bandage (21 CFR 880.5075): Class I and exempt from 510(k). A 2023 review in Plastic and Reconstructive Surgery Global Open found limited high-quality evidence for routine use, with benefit shown for some outcomes (such as pain) and none shown for others.
Definition and scope
FDA defines an elastic bandage as “a device consisting of either a long flat strip or a tube of elasticized material that is used to support and compress a part of a patient’s body” (21 CFR 880.5075, eCFR, checked 2026-10-30). FDA’s product classification database lists the matching product code, MHW, under the device name “Dressing, compression” (checked 2026-10-30).
In practice the term covers shaped garments for different body areas. The review by Ormseth and colleagues names abdominal binders, compressive bras, compressive masks, elastic bandaging and nasal splints, foam compression wraps and pressure dressings, surgical hose and tubular elastic support such as Tubigrip.
How it is used in practice
Surgeons prescribe or recommend garments after many operations, but the review reports limited high-quality evidence to inform best practice and encourages surgeons to critically reassess their use of compression garments and to discuss risks, benefits and cost with patients. The review does not define formal garment grades or stages. It cites one manufacturer-sponsored 1989 study, not peer reviewed, that suggested 17-20 mm Hg for skin outcomes worn for 3-8 weeks; that is a single report, not a standard.
Evidence by procedure type
The table restates what the review reports for each area. It is a summary of published evidence, not a recommendation.
| Area or procedure | Garment type | What the review reports |
|---|---|---|
| Rhinoplasty | Elastic bandaging; nasal splint | Elastic bandaging reduced edema and bruising in one 2020 randomized trial; nasal splinting was not shown to improve outcomes. |
| Facelift, neck lift, buccal fat | Compression dressings | Sparse, low-quality evidence with no randomized trials; compression likely does not reduce facelift hematoma. |
| Breast surgery | Compressive bra | One 2023 randomized trial in breast cancer surgery found reduced pain; no benefit for complications after augmentation; evidence on seroma inconsistent. |
| Abdominal surgery (abdominoplasty, laparotomy, hernia) | Abdominal binder | May reduce early postoperative pain; did not reduce seroma in abdominoplasty trials; concerns raised about lung function, intra-abdominal pressure and venous flow; one study found increased subcutaneous edema. |
| Liposuction, brachioplasty | Body-contouring garments | No randomized or comparative studies; the value is unknown. |
The review also lists documented downsides: discomfort (39% of one breast augmentation group complained), venous stasis with a possible thrombosis risk, skin defects and necrosis, reduced lung function in one abdominoplasty study, raised intra-abdominal pressure, and, in a study of incorrectly sized graduated compression stockings in postoperative orthopedic patients that the review cites, poor fit in 4% to 44% of patients.
Where it matters for labs, clinics and supply decisions
Regulatory class
Elastic compression products sit with the elastic bandage: Class I under general controls, exempt from 510(k) subject to 21 CFR 880.9, and exempt from most quality-system requirements except records and complaint files (21 CFR 880.5075, checked 2026-10-30). FDA’s classification entry for code MHW describes the same exemptions where the product is not labeled sterile.
Leg stockings are regulated separately. Under 21 CFR 880.5780, a medical support stocking “designed to apply controlled pressure to the leg” to prevent pooling of blood in the legs is Class II with special controls (paragraph a); the same construction for other medical purposes is Class I (paragraph b). The stocking rule does not address torso, bra or face garments.
Garment versus DVT stocking
The two product groups answer different questions. For graded stockings used for venous thromboembolism prevention, see DVT prophylaxis compression stockings, TED hose and compression socks. For area-specific support, see abdominal binders and elastic bandages.
Fit is a documented problem
The review cites a study of incorrectly sized graduated compression stockings in postoperative orthopedic patients that put poor fit at 4% to 44%. A garment that is documented as ordered is not necessarily one that fits; that figure is for stockings, not post-surgical garments. Clinics that stock or supply garments can see how this fits into wider post-operative stocking in the cosmetic surgery clinic supply checklist.
Common misunderstandings
- “Compression garments are proven to prevent complications.” The review found no consistent proof: seroma was not reduced in abdominoplasty trials and facelift hematoma likely is not reduced.
- “A compression garment is the same as a DVT stocking.” They are classified separately; leg stockings that prevent blood pooling are Class II under 21 CFR 880.5780(a).
- “Tighter is better.” The review lists skin defects, necrosis, venous stasis and reduced lung function among documented risks, and the only pressure figure it cites is from a single non-peer-reviewed study.
- “Class I means clinically proven.” Class I with 510(k) exemption describes the regulatory pathway; it is not a finding of clinical benefit.
FAQ
What is a post-surgical compression garment?
An elastic garment worn over an operated area to support and compress it, falling under FDA’s elastic bandage definition in 21 CFR 880.5075.
Is a post-surgical compression garment a medical device in the US?
Yes. FDA lists compression dressings under product code MHW as Class I, exempt from 510(k).
Does the evidence support routine use?
The 2023 review found limited high-quality evidence, with benefit for some outcomes (pain after some breast and abdominal surgery, bruising after rhinoplasty in one trial) and none shown for others.
How is it different from compression stockings?
Leg stockings that prevent blood pooling are Class II under 21 CFR 880.5780(a); area-specific garments follow the elastic bandage classification.
Sources
- FDA, 21 CFR 880.5075 Elastic bandage, eCFR: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-880/subpart-F/section-880.5075 (checked 2026-10-30)
- FDA Product Classification, code MHW “Dressing, compression”: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm?ID=MHW (checked 2026-10-30)
- FDA, 21 CFR 880.5780 Medical support stocking, eCFR: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-880/subpart-F/section-880.5780 (checked 2026-10-30)
- Ormseth BH, Livermore NR, Schoenbrunner AR, Janis JE. The Use of Postoperative Compression Garments in Plastic Surgery: Necessary or Not? A Practical Review. Plast Reconstr Surg Glob Open. 2023;11(9):e5293. https://pmc.ncbi.nlm.nih.gov/articles/PMC10519563/ (checked 2026-10-30)
